---
title: "美國 FDA 批准 Tremfya 用於治療兒童斑塊型銀屑病"
description: "強生：美國 FDA 批准 TREMFYA®（古塞庫單抗）用於治療兒童斑塊型銀屑病和活動性銀屑病關節炎，標誌着 IL-23 抑制劑的首次也是唯一批准"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/259343926.md"
published_at: "2025-09-29T12:33:32.000Z"
---

# 美國 FDA 批准 Tremfya 用於治療兒童斑塊型銀屑病

> 強生：美國 FDA 批准 TREMFYA®（古塞庫單抗）用於治療兒童斑塊型銀屑病和活動性銀屑病關節炎，標誌着 IL-23 抑制劑的首次也是唯一批准

強生：

-   美國 FDA 批准 TREMFYA®（古塞庫單抗）用於治療兒童斑塊型銀屑病和活動性銀屑病關節炎，標誌着 IL-23 抑制劑的首次也是唯一的批准。

### Related Stocks

- [JNJ.US - 強生](https://longbridge.com/zh-HK/quote/JNJ.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| U.S. FDA Approves Johnson & Johnson’s TREMFYA® as First IL-23 Inhibitor for Pediatric Plaque Psoriasis and Psoriatic Arthritis | Johnson & Johnson has received FDA approval for TREMFYA® (guselkumab) as the first IL-23 inhibitor for treating pediatri | [Link](https://longbridge.com/zh-HK/news/259334017.md) |
| J&J gets FDA approval for Tremfya in paediatric psoriasis | Johnson & Johnson's Tremfya (guselkumab) has received FDA approval for treating paediatric plaque psoriasis and active p | [Link](https://longbridge.com/zh-HK/news/259508546.md) |
| Experts who worry about child vaccination need to look in the mirror | The author expresses concerns about child vaccination, reflecting on personal experiences and the decline of trust in th | [Link](https://longbridge.com/zh-HK/news/275898026.md) |
| 08:03 ETMacPaw Introduces Kid Safe Mode, ClearVPN's New Feature to Strengthen Family Digital Safety | MacPaw has launched Kid Safe Mode in ClearVPN, enhancing online safety for children by blocking harmful content with a s | [Link](https://longbridge.com/zh-HK/news/275463059.md) |
| This court case could decide the future of childhood vaccines | A federal court is set to hear a lawsuit from the American Academy of Pediatrics challenging the Trump administration's  | [Link](https://longbridge.com/zh-HK/news/275932319.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。